Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Better Communication, Coordination May Aid CDI Prevention at VA Hospitals
08/17/2023
Jolynn Tumolo
“Recommendations include improving centrally-mandated clarity about and standardization of CDI prevention policies, including testing,” researchers wrote. 
“Recommendations include improving centrally-mandated clarity about and standardization of CDI prevention policies, including testing,” researchers wrote. 
“Recommendations include...
08/17/2023
First Report Managed Care
News
Parkinson Disease Care Coordinators Improve Quality of Life for Patients, Caregivers
08/17/2023
Jolynn Tumolo
Ongoing support, a care coordinator, and a personalized approach to address evolving needs at different disease stages may be effective in multisectoral integrated care initiatives for individuals with Parkinson disease and their caregivers. 
Ongoing support, a care coordinator, and a personalized approach to address evolving needs at different disease stages may be effective in multisectoral integrated care initiatives for individuals with Parkinson disease and their caregivers. 
Ongoing support, a care...
08/17/2023
Annals of Long-Term Care
News
Early, Late DLBCL Relapse Linked With Distinct Evolutionary Dynamics
08/17/2023
Jolynn Tumolo
“These observations have implications for clinical trial design and patient management, where early and late relapse patient populations should be considered separately and support additional molecular characterization of tumors at relapse to...
“These observations have implications for clinical trial design and patient management, where early and late relapse patient populations should be considered separately and support additional molecular characterization of tumors at relapse to...
“These observations have...
08/17/2023
First Report Managed Care
News
Glycemic Control Improves With 90-Day Digital Therapeutic Program for Type 2 Diabetes
08/16/2023
Jolynn Tumolo
Research testing the Fitterfly Diabetes CGM program shows potential improvement of glycemic control and weight loss for patients with type 2 diabetes.
Research testing the Fitterfly Diabetes CGM program shows potential improvement of glycemic control and weight loss for patients with type 2 diabetes.
Research testing the Fitterfly...
08/16/2023
First Report Managed Care
News
Hospital-Onset CDI Incidence, Antibiotic Use Drop With Two-Step Testing
08/16/2023
Jolynn Tumolo
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step testing for Clostridioides difficile infection may lead to a decrease in hospital-onset CDI and antibiotic use, suggesting improved diagnostic specificity and indirect reassurance against underdiagnosis and...
The implementation of two-step...
08/16/2023
First Report Managed Care
News
RSV Infection Takes Significant Long-Term Toll on Older Adults
08/16/2023
Jolynn Tumolo
“RSV-positive ARI poses significant long-term impacts on certain health-related quality of life beyond the significant short-term outcomes of RSV-positive ARI in older adults,” researchers wrote.
“RSV-positive ARI poses significant long-term impacts on certain health-related quality of life beyond the significant short-term outcomes of RSV-positive ARI in older adults,” researchers wrote.
“RSV-positive ARI poses...
08/16/2023
Pharmacy Learning Network
Ulotaront Misses Primary Endpoint in Two Phase 3 Trials of Adults With Schizophrenia
News
Ulotaront Misses Primary Endpoint in 2 Phase 3 Trials of Adults With Schizophrenia
08/15/2023
Jolynn Tumolo
Ulotaront is a TAAR1 agonist with 5-HT1A agonist activity that was granted Breakthrough Therapy Designation by the FDA for the treatment of schizophrenia in May 2019.
Ulotaront is a TAAR1 agonist with 5-HT1A agonist activity that was granted Breakthrough Therapy Designation by the FDA for the treatment of schizophrenia in May 2019.
Ulotaront is a TAAR1 agonist...
08/15/2023
Psych Congress Network
A woman with her eyes closed and illustrated brain waves
News
Quality Sleep, Lack of Sleep Apnea Linked With Better Global Cognition
08/15/2023
Jolynn Tumolo
Better sleep consolidation and the absence of sleep apnea were associated with better global cognition over 5 years in an analysis of middle-aged to older US adults across five independent community-based cohorts.
Better sleep consolidation and the absence of sleep apnea were associated with better global cognition over 5 years in an analysis of middle-aged to older US adults across five independent community-based cohorts.
Better sleep consolidation and...
08/15/2023
Neurology
News
Long-Acting Injectable Antiretroviral Could "Help End AIDS"
08/15/2023
Jolynn Tumolo
A coordinated effort involving governments, large funders, and manufacturers is essential for the rollout of long-acting and extended-delivery antiretroviral medication to effectively fight against the HIV epidemic, according to a commentary...
A coordinated effort involving governments, large funders, and manufacturers is essential for the rollout of long-acting and extended-delivery antiretroviral medication to effectively fight against the HIV epidemic, according to a commentary...
A coordinated effort involving...
08/15/2023
First Report Managed Care
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
News
No Difference in Neurodevelopmental Outcomes With Fetal Antiseizure Drug Exposure
08/14/2023
Jolynn Tumolo
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did not differ between 3-year-olds who were exposed to antiseizure medications in utero and their peers who were not exposed, according to a study published in The Lancet Neurology.
Neurodevelopmental outcomes did...
08/14/2023
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use